 The purpose of this study is to determine whether PTK787ZK 222584 is effective in treating hemangioblastoma of the brain andor retina in patients with von Hippel-Lindau disease. The study will also assess safety and tolerability of PTK787ZK 222584, and changes in markers of angiogenesis new blood vessel growth. 